Bone Marrow Cells and Gastric Cancer Outcomes
Author Information
Author(s): de Manzoni G, Pelosi G, Pavanel F, Di Leo A, Pedrazzani C, Durante E, Cordiano C, Pasini F
Primary Institution: Università di Verona, Verona, Italy
Hypothesis
Does the presence of bone marrow cytokeratin-positive cells predict outcomes in gastric cancer patients?
Conclusion
The presence of cytokeratin-positive cells in the bone marrow of curatively resected gastric cancer patients did not affect their outcomes.
Supporting Evidence
- 29% of patients had cytokeratin-positive cells in their bone marrow.
- Median survival was similar for patients with and without cytokeratin-positive cells.
- Recurrence rates were comparable between cytokeratin-positive and negative subsets.
Takeaway
This study looked at whether certain cells in the bone marrow could tell us how well gastric cancer patients would do after surgery, and it found that they don't really help us predict that.
Methodology
Bone marrow aspirates were taken from 114 gastric cancer patients and analyzed for cytokeratin-positive cells using immunocytochemistry.
Potential Biases
Potential bias due to variability in immunocytochemical techniques and observer interpretation.
Limitations
The study did not find a correlation between the presence of cytokeratin-positive cells and survival or clinicopathological factors.
Participant Demographics
Median age was 67 years, with a male-to-female ratio of about 2 to 1 (73 men).
Statistical Information
P-Value
0.9
Statistical Significance
p=0.9
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website